BILDSTRECKE: AstraZenecas Covid-Medikament "Evusheld"
  • Download von www.picturedesk.com am 23.02.2022 (10:39). A photo taken on February 8, 2022 shows a box of Evusheld, a drug for antibody therapy developed by pharmaceutical company AstraZeneca for the prevention of COVID-19 in immunocompromised patients at the AstraZeneca facility for biological medicines in Södertälje, south of Stockholm, Sweden. - AstraZeneca’s new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) - 20220208_PD24864 - Rechteinfo: Rights Managed (RM) Nur für redaktionelle Nutzung! Werbliche Nutzung erfordert Freigabe: bitte schicken Sie uns eine Anfrage.
    1 /5 Das Covid-Prophylaxe-Medikament "Evusheld" soll einen Schutz für Hochrisiko-Patienten, bei denen eine Impfung keine Option ist, bieten können.
    ...
    JONATHAN NACKSTRAND / AFP / picturedesk.com
  • Download von www.picturedesk.com am 23.02.2022 (10:39). Packages of a test production are pictured on the assembly line for automatic packaging at the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZeneca’s new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) - 20220208_PD24922 - Rechteinfo: Rights Managed (RM) Nur für redaktionelle Nutzung! Werbliche Nutzung erfordert Freigabe: bitte schicken Sie uns eine Anfrage.
    2 /5 Es wird in einer hochmodernen Produktionsanlage im schwedischen Södertälje durch AstraZeneca hergestellt.
    ...
    JONATHAN NACKSTRAND / AFP / picturedesk.com
  • Download von www.picturedesk.com am 23.02.2022 (10:40). AstraZeneca's President for the Nordic countries Anna-Lena Engström poses for photos outside the company's facility for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZeneca’s new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) - 20220208_PD24782 - Rechteinfo: Rights Managed (RM) Nur für redaktionelle Nutzung! Werbliche Nutzung erfordert Freigabe: bitte schicken Sie uns eine Anfrage.
    3 /5 AstraZeneca'-Präsidentin für Skandinavien Anna-Lena Engström vor dem im Dezember 2021 eröffneten Werk.
    ...
    JONATHAN NACKSTRAND / AFP / picturedesk.com
  • Download von www.picturedesk.com am 23.02.2022 (10:38). Employees work at the assembly line of the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZeneca’s new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) - 20220208_PD24932 - Rechteinfo: Rights Managed (RM) Nur für redaktionelle Nutzung! Werbliche Nutzung erfordert Freigabe: bitte schicken Sie uns eine Anfrage.
    4 /5 Dort sollen neben Evusheld auch Impfstoffe der nächsten Generation hergestellt werden.
    ...
    JONATHAN NACKSTRAND / AFP / picturedesk.com
  • Download von www.picturedesk.com am 23.02.2022 (10:40). Vials of a test production are pictured at the assembly line of the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZeneca’s new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people.  (Photo by Jonathan NACKSTRAND / AFP) - 20220208_PD24933 - Rechteinfo: Rights Managed (RM) Nur für redaktionelle Nutzung! Werbliche Nutzung erfordert Freigabe: bitte schicken Sie uns eine Anfrage.
    5 /5
    ...
    JONATHAN NACKSTRAND / AFP / picturedesk.com
Zur Startseite
Jetzt E-Paper lesen